DaVita research indicates effectiveness of mRNA vaccine in dialysis patients

Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively

Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines

This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs

Daiichi Sankyo initiates Phase 2 trial of mRNA Covid-19 vaccine in Japan

It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus

Moderna presents data from Phase 1 study of mRNA Triplet programme

The interim data combines three mRNAs into one therapy injected directly into the tumour

Sanofi says positive results from flu vaccine with mRNA booster study

The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older

Moderna to build mRNA facility in Africa

The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come

Second-Gen mRNA COVID-19 vaccine candidate CV2CoV show positive signs in preclinical study

The preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVac’s first-generation mRNA backbone

Moderna to set up mRNA manufacturing in Canada

The collaboration will support Canada with direct access to rapid pandemic response capabilities

Dr. David Berman to Join Moderna as Chief Development Officer

Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics

Moderna teams up with Recordati to commercialize rare disease therapy